Virtus LifeSci Biotech Clinical Trials ETF
16 hedge funds and large institutions have $1.99M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$2.5M | |
| 2 | -$722K | |
| 3 | -$551K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$494K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$82.2K |